Thursday, December 8, 2022
News
NEWS HOME
PRN INDIA
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
  SocialTwist Tell-a-Friend  
   

The FDA has assigned a PDUFA goal date of March 29, 2023 for the NDA submission based on randomized-controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency

LEIDEN, The Netherlands, Sept. 28, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) announces that the US Food and Drug Administration (FDA) has accepted for priority review its New Drug Application (NDA) for leniolisib, an oral, selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, to treat the rare primary immunodeficiency activated phosphoinositide 3-kinase delta syndrome (APDS) in adults and adolescents 12 years of age and older in the US. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 29, 2023, aligned with a Priority Review classification.

Pharming Group NV Logo

Submitted by Pharming on July 29, 2022, the NDA was supported by positive data from a Phase II/III study of leniolisib, which met its co-primary endpoints of reduction in index lymph node size and correction of immunodeficiency in the target population. Those results demonstrated the efficacy of leniolisib over placebo with a statistically significant reduction from the baseline size of participants' index lymphadenopathy lesions (p=0.006) and normalization of their immune function, as evidenced by an increased proportion of naïve B cells from the baseline (p=0.002). Those findings indicate a reduction in disease markers associated with APDS, whose clinical hallmarks include significant lymphoproliferation and immune dysfunction, as well as increased risk of lymphoma. Furthermore, safety data from the study showed that leniolisib was well tolerated by participants. Also submitted as part of the application were data from a long-term, open-label extension clinical trial including 38 patients with APDS who were treated with leniolisib for a median of 102 weeks.

Anurag Relan, MD, MPH, Chief Medical Officer of Pharming, commented:
"The FDA's acceptance for priority review of Pharming's New Drug Application for leniolisib is a milestone that demonstrates our commitment to addressing unmet needs for patients with rare diseases. With FDA's review, leniolisib moves further along the regulatory pathway as a potential disease-modifying targeted treatment for APDS in adults and adolescents 12 years of age and older in the US, who currently rely on supportive therapies such as antibiotics and immunoglobulin replacement therapy. We look forward to continuing to work closely with the FDA, as well as with regulatory authorities across the globe, to make leniolisib available to immunologists, hematologists, and their APDS patients."

About Activated Phosphoinositide 3-Kinase δ Syndrome (APDS)
APDS is a rare primary immunodeficiency that affects approximately 1 to 2 people per million. It is caused by variants in either of two genes, PIK3CD or PIK3R1, that regulate maturation of white blood cells. Variants of these genes lead to hyperactivity of the PI3Kδ (phosphoinositide 3-kinase delta) pathway.1,2 Balanced signaling in the PI3Kδ pathway is essential for physiological immune function. When this pathway is hyperactive, immune cells fail to mature and function properly, leading to immunodeficiency and dysregulation.1,3 APDS is characterized by severe, recurrent sinopulmonary infections, lymphoproliferation, autoimmunity, and enteropathy.4,5 Because these symptoms can be associated with a variety of conditions, including other primary immunodeficiencies, people with APDS are frequently misdiagnosed and suffer a median 7-year diagnostic delay.6 As APDS is a progressive disease, this delay may lead to an accumulation of damage over time, including permanent lung damage and lymphoma.4-7 The only way to definitively diagnose this condition is through genetic testing.

About Leniolisib
Leniolisib is a small-molecule inhibitor of the delta isoform of the 110 kDa catalytic subunit of class IA PI3K with immunomodulating and potentially anti-neoplastic activities. Leniolisib inhibits the production of phosphatidylinositol-3-4-5-trisphosphate (PIP3). PIP3 serves as an important cellular messenger activating AKT (via PDK1) and regulates a multitude of cell functions such as proliferation, differentiation, cytokine production, cell survival, angiogenesis, and metabolism. Unlike PI3Kα and PI3Kβ, which are ubiquitously expressed, PI3Kẟ and PI3Kγ are expressed primarily in cells of hematopoietic origin. The central role of PI3Kẟ in regulating numerous cellular functions of the adaptive immune system (B-cells and, to a lesser extent, T cells) as well as the innate immune system (neutrophils, mast cells, and macrophages) strongly indicates that PI3Kẟ is a valid and potentially effective therapeutic target for several immune diseases. To date, leniolisib has been well tolerated during both the Phase 1 first-in-human trial in healthy subjects and the Phase II/III registration-enabling study.

About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn

Forward-Looking Statements
This press release contains forward-looking statements, including with respect to timing and progress of Pharming's preclinical studies and clinical trials of its product candidates, Pharming's clinical and commercial prospects, Pharming's ability to overcome the challenges posed by the COVID-19 pandemic to the conduct of its business, and Pharming's expectations regarding its projected working capital requirements and cash resources, which statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming's clinical trials and ramifications for the cost thereof; and clinical, scientific, regulatory and technical developments. In light of these risks and uncertainties, and other risks and uncertainties that are described in Pharming's 2021 Annual Report and the Annual Report on Form 20-F for the year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission, the events and circumstances discussed in such forward-looking statements may not occur, and Pharming's actual results could differ materially and adversely from those anticipated or implied thereby. Any forward-looking statements speak only as of the date of this press release and are based on information available to Pharming as of the date of this release.

Inside Information
This press release relates to the disclosure of information that qualifies, or may have qualified, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

References

  1. Lucas CL, et al. Nat Immunol. 2014;15:88-97.
  2. Elkaim E, et al. J Allergy Clin Immunol. 2016;138(1):210-218.
  3. Nunes-Santos C, Uzel G, Rosenzweig SD. J Allergy Clin Immunol. 2019;143(5):1676-1687.
  4. Coulter TI, et al. J Allergy Clin Immunol. 2017;139(2):597-606.
  5. Maccari ME, et al. Front Immunol. 2018;9:543.
  6. Jamee M, et al. Clin Rev Allergy Immunol. 2019;May 21.
  7. Condliffe AM, Chandra A. Front Immunol. 2018;9:338.

For further public information, contact:

Pharming Group, Leiden, The Netherlands
Heather Robertson, Investor Relations & Corporate Communications Manager
T: +31 71 524 7400
E: investor@pharming.com

FTI Consulting, London, UK
Victoria Foster Mitchell/Alex Shaw/Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

US PR:
Ethan Metelenis
T: +1 (917) 882 9038
E: Ethan.Metelenis@precisionvh.com

EU PR:
Dan Caley
T: +44 (0) 787 546 8942
E: Dan.caley@aprilsix.com

Logo - https://mma.prnewswire.com/media/1454235/Pharming_Group_NV_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/pharming-announces-us-fda-acceptance-for-priority-review-of-its-new-drug-application-for-leniolisib-301634871.html

More News by PR Newswire India

Double Peak Group Founder Undeterred by Economic Woes and Insolvency Crises, Maintains Belief in Blockchain's Potential

Hisense Expands Its Global Influence with Cutting-Edge Technology

Get a Unique Travel Experience with FindGuide

Sourcing has a new name in India - ANT MASCOT

Daughter of Honey and Barry Sherman Issues Plea for Information on 5th Anniversary of Murders; Crime Remains Unsolved

The last Date to Apply for IBSAT 2022 for All 9 Campuses of ICFAI Business School is Closing Soon

TerraPay wins the 'Best use of data' award at the prestigious Banking Tech Awards 2022

Infosys Research: Nine out of Ten Executives Report ESG Delivers ROI

ProV Foods partners with celebrity chef Sanjeev Kapoor and food & FMCG industry veteran KS Narayanan to drive brand salience and growth

Deakin University, Australia partners with Indian universities led by IIT Madras to launch Australia - India Centre for Energy to ensure access to affordable, reliable, sustainable, and modern energy for all

Vantage's swap-free trading provides gold traders nearly US$1million in savings over a three-month period

Deutsche Bank celebrates 150 years in Asia Pacific and 42 years in India, hosts unique Art Event

Incredible viewing figures for the Golden Trail World Series in 2022!

Junglee Rummy's Great Winning Festival campaign concludes after 2-month long intense competition

PARAMOUNT+ ARRIVES IN GERMANY, AUSTRIA, AND SWITZERLAND, CONCLUDING A YEAR OF GLOBAL EXPANSION

The Metaverse and NFTs of The Abode of Chaos dixit NYT, Contemporary Art Museum and headquarters of Artprice by Artmarket.com - a reality according to n°2208 of the monthly magazine Géomètre (creation 1847)

2023 Colliers Global Investor Outlook report: Global real estate market stabilisation to take hold in a return to relative rationality

Mission Harm Reduction: Embracing Innovations and New Global Regulatory Insights to Save Lives

enreap Partners with Planview as a Solution Partner

New Study Finds that it Takes 32 days for Companies to hire a Candidate

Yili's Premium Brand SATINE Responds to COP15's Call to Build a Shared Future for All Life on Earth with Its Ongoing Commitment to Preserving Biodiversity

University of Technology Sydney and Cricket NSW join forces in strategic partnership to benefit local and international cricket communities

Rising economies flock to instant alternative payments vs. cards in the world's most innovative regions for fintechs, per EBANX's annual Beyond Borders report

Microland Recognized as a Leader for the Third Consecutive Year in the 2022 Gartner® Magic Quadrant™ for Managed Network Services

Schneider Electric Applauded by Frost & Sullivan for Decreasing Unplanned Downtimes/Outages and Carbon Footprint with Its Sustainable Switchgear

INX TO LAUNCH PLATFORM ON AVALANCHE BLOCKCHAIN, EXPANDING INFRASTRUCTURE FOR SECURITY TOKEN ISSUERS

The 5th Edition of the WTCA Prime Office Index LatAm Shows Increasingly Optimistic Projections for the Premium Office Segment in Latin America

IWL and Hawesko build on agile omnichannel fulfillment with AMR solution from Körber

Kapil Dev Tees off at HSBC Golf League Regional Round North India powered by Thriwe

SQUADRON TO LEAD AUSTRALIA'S ENERGY TRANSITION

Lost childhood: a 'tight-knit' network to combat abuse and distress

China Matters presents "The Glory Days on the Ice," telling the unique story of an ice hockey team in Beijing

SPJIMR hosts the AACSB 'Societal Impact Seminar'

Speedgoat announces new generation Performance real-time test system, accelerating testing of control designs and embedded controllers from Simulink®

CRISIL Retains Zensciences for its Digital Marketing Mandate

HarperCollins is proud to announce the official autobiography of one of the greatest fast bowlers in the history of cricket

The First Bengaluru Arthroscopy Course - An Educational Initiative by Manipal Hospital Millers Road & Indian Arthroscopy Society

CHT Security Applauded by Frost & Sullivan for Its Leadership Position as a Managed Security Service Provider in Taiwan

Decarbonization Solution Provider 3DOM Singapore unveils new name, "noco-noco"

The Mall Group: Promoting Thailand as the ideal shopping destination for India and Bangladesh

CGTN: China sees off Comrade Jiang Zemin, pooling strength for striving forward

IIITH's social incubator, AIC-IIITH onboards startups for EPAM Social Impact Innovation Program

2022 Yidan Prize Summit: Providing a Platform to Spotlight Educator Development and Empowerment

Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood

UST Collaborates with Intel and SAP to Digitize the Industry 4.0 Journey for Malaysian SMEs

Chandigarh University launches Mobile Science Bus; aims to cover 100% schools in Chandigarh

14th GREENSTORM GLOBAL PHOTO FESTIVAL BEGINS

Sahyadri Hospitals clocks 300 liver transplants

Şişecam India launches IMPRESSIONS 2023, the First design book for Glass Industry in India featuring 25 Stalwarts from Architecture & Design community.

Bigger growth opportunities beckon for partners who rewrite the rules of cybersecurity with Infoblox

Cybersecurity resilience emerges as top priority as 62 percent of companies say security incidents impacted business operations

Vymo's Yamini Bhat recognized in BW Disrupt 40 under 40 for building one of the fastest-growing Enterprise SaaS companies globally

IBM and David Clark Cause Aim to Reduce Food Waste; Name AI-Powered Gardening App Winner of 5th Annual Call for Code

Locus Launches Delivery Linked Checkout, A First-Of-Its-Kind Integrated Capability Enabling Retail Businesses to Achieve Profitability in Last-Mile Logistics

20th Century Studios, Lightstorm Entertainment and James Cameron's AVATAR: THE WAY OF WATER Dives Into Visually Immersive ScreenX and Multi-Sensory 4DX Theaters

GWM Global Smart Plant Facilitates New Energy Transformation and Upgrading

ViewSonic Introduces Its First Portable Monitor with OLED Technology for Creators

New International Consensus on CGM Clinical Trial Metrics Aims to Spur Diabetes Treatment Advances

Healthcare Summit Convened to Address Maternal-Fetal Outcomes in Sub-Saharan Africa

Sonatype Applauded by Frost & Sullivan for Enabling Detection, Analysis, and Remediation of Vulnerabilities in SDLC with Its Nexus Platform

Midco launches rock-solid in-home wireless powered by Plume HomePass and OpenSync

Spiers New Technologies Recognized by Frost & Sullivan for Its Market Leadership in the Electric Vehicle Battery 4R Services Industry

inVia Robotics Earns Frost & Sullivan's 2022 North American Technology Innovation Leadership Award for Its Highly Differentiated Products and Robotics-as-a-service Model

Delta Controls Applauded by Frost & Sullivan for Its Innovative, Customer-centric Products and Competitive Strategy in Building Automation

Dubai-based DAMAC Group signs contract with Mandarin Oriental to manage luxurious resort in The Maldives

Counterpoint Whitepaper on The Rise of TECNO: TECNO plays a leading role in the premium evolution of the 5G Smartphone industry in Global Emerging Markets

Sungrow Volunteer Week: Call for More Actions Contribute to SDGs

APJ Financial Services: Akamai Research Shows APJ Surpasses North America in Web Application and API Cyberattacks Against Financial Services

G-P Announces New Chief Revenue Officer, Vernon Irvin

Arsenal and LABS Group announce new partnership

Clarivate Expands Real World Data and Analytics Solutions with Addition of U.S. Specialty Pharmacy Data

COP15: An International Conference on Solutions to the Underlying Causes of Biodiversity Loss

AppViewX continues to strengthen its presence in India; announces Deloitte Technology Fast 500 ranking for 2022

Aryaka Certified as an "Attractive Employer" by Great Place to Work® in the United States, India, and Germany

Addionics Applauded by Frost & Sullivan for Improving Rechargeable Battery Architecture with Its Smart 3D Electrode Technology

Softbrik: New Study reveals a 78% Increase in Voice Searches in India

The LEGO Foundation Announces Recipients of US$117 Million Global Challenge

Fremaux Delorme, French home linens for la Crème de la crème, now in India

Almost 30,000 enter #HalfTimeForOman competition as Oman celebrates the 2022 FIFA World Cup with a chance to win a free holiday

STL appoints Tushar Shroff as Group Chief Financial Officer

THE LEELA PALACES, HOTELS AND RESORTS LAUNCHES 'THE LEELA PALACE TRAIL' - A CURATED ITINERARY SHOWCASING THE QUINTESSENCE OF INCREDIBLE INDIA

Scytáles AB together with Netcompany-Intrasoft wins landmark EU Digital Wallet contract

Hinduja Tech Acquires Drive System Design, Expands Leadership in the Global eMobility Industry

Curadev Pharma Receives FDA 'Study May Proceed' Letter for its Investigational New Drug Application of CRD3874, an IV-Administered STING Agonist for the treatment of advanced/metastatic solid cancers

From Peace Corps to The Fashion Awards Red Carpet - Model, Pooja-Accamma Somaiah, continues her remarkable journey advocating for South Asian representation and breaking stereotypes in the fashion industry

Football and art come together in the first NFT exhibition of its kind

Great Place to Work® recognizes Xoxoday for its people-first culture

Standyou is facilitating fully funded scholarship-based admissions for higher education in more than 10 countries

MapMyGenome launches its affordable Pharmacogenomics solution MedicaMap covering more than 165 drugs

Trainocate Awarded 2022 Regional and Global AWS Partner Award

Aloe Vera of America Receives Award for Environmental Health Efforts

stake.link Delivers Liquid Delegated Staking to the Chainlink Ecosystem with Consortium of Node Operators

QATAR FASHION UNITED BY CR RUNWAY PRESENTS POST MALONE IN CONCERT ON 16 DECEMBER

Swarovski Group Employees Volunteer with Swarovski Foundation Partner Teach for Thailand to Support Equitable Education for Young People

Luxembourg selects Intersec for its new Public Warning System

Future Minerals Forum enlists think tanks to champion innovation and develop thought leadership

GWM Deepens Its Global New Energy Strategy

Firmenich announces Dragon Fruit as 2023 Flavor of the Year

Hisense Advances Growth Strategy in the Middle East Market, Stepping Up Its Globalization Efforts

MIT Technology Review Insights' Blue Technology Barometer weighs the state of oceans in its second annual ranking

Space Software Provider Antaris™ Announces Launch Readiness of World's First Cloud-Built Demonstration Satellite

Tusk Innovation Announces New Products 'Combo'

The Embassy of Italy is organizing the 7th edition of World Week of Italian Cuisine in India

Evolutio is First European Provider to Deploy Ribbon's Virtual C20 for Telecom Services

Delta Controls Applauded by Frost & Sullivan for Its Advanced Building Control Products, Seamless Systems Tech Developments, and Market-leading Position

Mintoak develops merchant solutions to fuel business growth for MSMEs

Inkspell, in partnership with NMIMS SOBA, brought an exclusive, in-person edition of the AdWorld Showdown 2022 - The Ultimate Battle of Branding & Advertising

ACE Green Recycling Signs Inter-Continental Offtake Agreement with Glencore

HRH Prince Mohammed bin Salman announces Sindalah, NEOM's first island development

MBA student bags a half-crore package with Microsoft, at Goa Institute of Management

Cinthol's new campaign reflects women's increasing aspirations of taking on challenging roles in nation building

Sai Life Sciences releases its Sustainability Report 2022

Prosus SICA announces India's most innovative assistive tech start-ups in 2022

IIIT Hyderabad to host 2nd annual Conference on Data Driven Tech on 17 Dec., 2022

'Heart failure is no longer Life failure' as JB Pharma decreases price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan®) by nearly 50%

New Satellite Design Advances Fuel Market Growth for Satellite Propulsion Solutions

The 2022 ITOE Senior Care & Rehabilitation Expo Kicks Off

SafeTree: Embedded Insurance - Huge opportunity to increase Insurance Penetration in India

Stunning new acquisition for ever-expanding Icelandic hotel operator

All aboard the Heathrow Festive Express

Generators and Buses Powered By Yuchai Engines Featured in Football Premium events in Qatar

Tata AIA Life Certified as a Great Place to Work®, Enhancing Best Employer Reputation

Bucking trends ailing other edtech companies, upGrad-backed Harappa launches in the US with plans to upskill 55,000 managers in 3 years

Trina Solar vows to build a net-zero world with responsibility, technology and vision

TECNO and Google Strategically Partner to Upgrade User Experience

DTDC, one of India's leading integrated express logistics companies adopts global location technology what3words to revolutionise deliveries across India

Bitget shares Merkle Tree Proof of Reserves to enhance transparency

DEKRA Positioned for the Future Thanks to Focus on Safety, Security and Sustainability

Woxsen University concludes its Convocation Ceremony for MBA & B.Des Programs

Newland AIDC boosts its presence in India with the launch of a state-of-the-art service entity

BE OPEN Launches #BEOPENStaringAtTheSun Open Call to support UN's SDG7: Affordable and Clean Energy

ROLLER celebrates gaining Great Place to Work® certification

International Aluminium Institute Launches Report on the Industry's Contribution to the United Nations Sustainable Development Goals

GEEKOM's Christmas Gift for Wholesale Buyers - Lowest Mini PC Price When Order 10 Units

Sims Limited Pledges to Achieve Gender Balance in Executive Leadership by 2030

Unleash your creativity and passion for technology. Join NMIMS School of Design's B.Des. (Humanising Technology) program

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Excise officials seize liquor worth Rs 4...
BJP's Sanjay Jaiswal raises Bhagalpur mu...
Gujarat polls: BJP confident of retainin...
Bypolls results: Counting of votes for 6...
Govt working towards establishing Uttara...
Kerala government tables University Laws...
More...    
 
 Top Stories
Sara Ali Khan wishes her grandmothe... 
Delhi HC issues summons former MD G... 
Sushil Modi demands Nitish Kumar's ... 
PM Modi thanks "champion" BJP karya... 
Rahul Gandhi extends "heartfelt tha... 
Govt extends rooftop solar scheme t... 
UP Governor to inaugurate two-day H... 
Himachal continues its trend of alt...